Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$248K Hold
10,933
0.01% 692
2026
Q1
$255K Hold
10,933
0.01% 657
2025
Q4
$219K Buy
10,933
+492
+5% +$9.61K ﹤0.01% 685
2025
Q3
$191K Buy
10,441
+8
+0.1% +$156 ﹤0.01% 738
2025
Q2
$210K Hold
10,433
﹤0.01% 710
2025
Q1
$189K Buy
+10,433
New +$187K ﹤0.01% 700

Other funds holding INVA

Bailard's INVA Position: Q2 2026 in Review

Bailard held its Innoviva (INVA) position steady in Q2 2026 at 10,933 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #692.

Bailard first reported a position in INVA in Q1 2025 and has held it in 6 quarters since. The position peaked at $255K in Q1 2026. 308 funds tracked by Wall St. Rank hold INVA as of Q2 2026.

  • Bailard held 10,933 shares of Innoviva worth $248K as of Q2 2026.
  • Bailard left its Innoviva share count unchanged in Q2 2026.
  • Innoviva made up 0.01% of Bailard's portfolio in Q2 2026, its #692 holding.
  • Bailard first reported a position in Innoviva in Q1 2025 and has held it in 6 quarters since.
  • Bailard's Innoviva position peaked at $255K in Q1 2026.
  • 308 funds tracked by Wall St. Rank held Innoviva as of Q2 2026.

Based on Bailard's 13F filing for Q2 2026, filed 30 Jul 2026.